Table 1.
Baseline and clinical characteristics of 32 neonates with neonatal thrombosis.
| Treatment group (n = 25) | “Wait-and-see” group (n = 7) | Total (n = 32) | |
|---|---|---|---|
| Female gender, n (%) | 15 (60) | 4 (57) | 19 (59) |
| Gestational age (weeks)* | 30 (27–38) | 28 (25–36) | 29 (27–38) |
| <32, n | 15 | 5 | 20 |
| 32 ≪ 37, n | 2 | 1 | 3 |
| >37, n | 8 | 1 | 9 |
| Birthweight (g)* | 1256 (817–3300) | 938 (734–2735) | 1145 (789–3230) |
| <1000, n | 8 | 4 | 12 |
| 1000 ≪ 1500, n | 6 | 1 | 7 |
| >1500, n | 11 | 2 | 13 |
| UC, n (%) | 18/23 (78) | 5 (71) | 23/30 (77) |
| PICC, n (%) | 14/22 (64) | 4 (86) | 16/30 (53) |
| Either UC or PICC, n (%) | 22/23 (96) | 7 (100) | 29/30 (97) |
| Platelet transfusionsa n (%) | 11/21 (52) | 2 (29) | 13/26 (50) |
*Data presented as median (interquartile range (IQR)).
aDuring total hospital stay.